Explore this technical note introducing ChromaLIVE™ Deep Red, a novel non-toxic dye optimized for compatibility with NucleoLIVE™ Red. This new variation of our signature ChromaLIVE™ stain addresses limitations in traditional endpoint high-content screening and cell...

Cell viability and cell death assays are essential tools to evaluate compound cytotoxicity in drug discovery. While many commercial solutions exist, most are endpoint assays that only capture a snapshot at a single timepoint. MortaLIVE™...

Discover new insights into Immune Cell Killing (ICK) assays with this application note that describes a novel application for ChromaLIVE™, a non-toxic dye used in live-cell imaging to provide continuous and quantitative monitoring of effector-target...

Unlock new compound insights in long-term live-cell assays by combining ChromaLIVE™ Non-Toxic Dye with The Incucyte® Live-Cell Analysis System. This application note, developed in collaboration with Sartorius, guides users on leveraging these two live-cell technologies...

Explore our collaboration with Merck! Our poster, "Morphological Profiling: Comparing Cell Painting and Live Cell Painting for Deconvoluting Cellular Toxicity Kinetics and Types of Cell Death Mechanisms in High-Throughput", showcases ChromaLIVE™. This study, utilizing Merck's...

This poster, a collaboration with Yokogawa and SUN Bioscience, showcases an innovative workflow for kinetic morphological profiling of live 3D spheroid models. Learn how ChromaLIVE™ Live Cell Painting assay provides non-toxic staining of live cells...

This poster, in collaboration with NTNU and Mayo Clinic, reveals how NucleoLIVE™, our non-toxic nuclear dye, revolutionizes long-term live imaging of 2D and 3D cell cultures. NucleoLIVE™ effectively overcomes the limitations of existing nuclear dyes...

Discover how ChromaLIVE™ redefines Live Cell Painting with unsurpassed performance for phenotypic profiling. This technical note showcases ChromaLIVE™ as a non-toxic dye that excels in live-cell imaging, boosting bioactive compound detection and minimizing false predictions...

An Exploration Of Time-Dependent Phenotypic Changes For Enhanced Drug Discovery

Here is a poster presented at SBI2 in collaboration with: Mayo Clinic. This poster reveals how NucleoLIVE™, our non-toxic biocompatible nuclear probe, is designed to study long-term changes of cell populations. It addresses the limitations...